GRX | XLV | GRX / XLV | |
Gain YTD | 1.318 | -0.664 | -199% |
Net Assets | 169M | 35B | 0% |
Total Expense Ratio | 1.99 | 0.08 | 2,488% |
Turnover | 19.00 | 3.00 | 633% |
Yield | 0.27 | 1.76 | 15% |
Fund Existence | 18 years | 27 years | - |
GRX | XLV | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago86% | 1 day ago78% |
Momentum ODDS (%) | 3 days ago83% | 1 day ago74% |
MACD ODDS (%) | 3 days ago83% | 1 day ago82% |
TrendWeek ODDS (%) | 3 days ago87% | 1 day ago82% |
TrendMonth ODDS (%) | 3 days ago84% | 1 day ago84% |
Advances ODDS (%) | 4 days ago87% | 3 days ago82% |
Declines ODDS (%) | 24 days ago81% | 23 days ago82% |
BollingerBands ODDS (%) | 3 days ago80% | 1 day ago79% |
Aroon ODDS (%) | N/A | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BOIL | 52.55 | 1.82 | +3.59% |
ProShares Ultra Bloomberg Natural Gas | |||
MHD | 11.16 | -0.02 | -0.18% |
Blackrock Muniholdings Fund | |||
DVOL | 34.75 | -0.28 | -0.79% |
FirstTrustDorseyWrightMomt&LwVolatil ETF | |||
DON | 49.09 | -0.67 | -1.35% |
WisdomTree US MidCap Dividend ETF | |||
BBC | 19.85 | -0.34 | -1.68% |
Virtus LifeSci Biotech Clinical Trls ETF |
A.I.dvisor tells us that GRX and JNJ have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRX and JNJ's prices will move in lockstep.